Mayo Clinic Center for Cell Signaling in Gastroenterology announces awardees of Pilot and Feasibility Program

The Mayo Clinic Center for Cell Signaling in Gastroenterology announces the 2020–21 awardees of its Pilot and Feasibility Program. The primary goal of the program is to support new investigators just beginning their careers in digestive diseases research. The program provides investigators with sufficient funds to obtain robust preliminary data to be used in research grant applications awarded by external agencies, especially the National Institute of Diabetes and Digestive and Kidney Diseases.

Awardees and projects

Gianluca Cipriani, Ph.D. (GI ’15)
Gastroenterology Research
"Understanding Mechanisms by Which Muscularis Macrophages Modulate and Sustain Myenteric Neurons in Health and Disease"

Moira Hilscher, M.D. (I ’16, GI ’19)
Gastroenterology Research
"Elucidating the Neutrophil-Platelet Interactions That Drive Sinusoidal Thrombosis and Portal Hypertension"

Petra Hirsova, Pharm.D., Ph.D. (GI ’16)
Gastroenterology Research
"ROCK1 Inhibition Limits the Progression of Nonalcoholic Steatohepatitis"

Diana Jurk, Ph.D. (PHYS '18)
Department of Physiology and Biomedical Engineering
"Investigate the Mechanisms Mediating Lipid Accumulation in Senescent Cells in the Liver"

Enis Kostallari, Ph.D. (GI ’16)
Gastroenterology Research
"Mechanisms of Fibrogenic Extracellular Vesicle Release"


Recommended reading

Posts about similar topics: